173 related articles for article (PubMed ID: 6971309)
1. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
Carter VC; Schaffer PA; Tevethia SS
J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309
[TBL] [Abstract][Full Text] [Related]
2. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
[TBL] [Abstract][Full Text] [Related]
3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
[TBL] [Abstract][Full Text] [Related]
5. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells.
Lawman MJ; Courtney RJ; Eberle R; Schaffer PA; O'Hara MK; Rouse BT
Infect Immun; 1980 Nov; 30(2):451-61. PubMed ID: 6969228
[TBL] [Abstract][Full Text] [Related]
7. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
Pfizenmaier K; Jung H; Starzinski-Powitz A; Röllinghoff M; Wagner H
J Immunol; 1977 Sep; 119(3):939-44. PubMed ID: 70478
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
Rola-Pleszczynski M
J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
[TBL] [Abstract][Full Text] [Related]
10. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
Zinkernagel RM; Althage A; Holland J
J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
[TBL] [Abstract][Full Text] [Related]
12. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
López-Guerrero JA; Alarcón B; Fresno M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of interleukin-2 and gamma globulin on immune dysfunction in a patient with severe mucocutaneous herpes simplex virus infection.
Wise SL; Yarbrough JA; Stafford CT; Leffell MS; Thompson WO; Ades EW
Ann Allergy; 1992 Jan; 68(1):47-52. PubMed ID: 1371040
[TBL] [Abstract][Full Text] [Related]
15. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
Mitchell BM; Stevens JG
J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.
Posavad CM; Newton JJ; Rosenthal KL
J Immunol; 1993 Nov; 151(9):4865-73. PubMed ID: 8409445
[TBL] [Abstract][Full Text] [Related]
17. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
Tigges MA; Leng S; Johnson DC; Burke RL
J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
[TBL] [Abstract][Full Text] [Related]
18. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
[TBL] [Abstract][Full Text] [Related]
19. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
20. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells.
Jennings SR; Rice PL; Kloszewski ED; Anderson RW; Thompson DL; Tevethia SS
J Virol; 1985 Dec; 56(3):757-66. PubMed ID: 2999432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
